Alumni

Former Ph.D Students

Dr. Divine P. Daniel

  • Batch - 2016-2021

  • Current position - Medical Science - Employee in Govt. of Kerala

  • Thesis Title - Synthesis of Ellipticine-Structural Modulated Analogs as Potential Antiproliferative Agents

Dr. Gulshan Kumar

  • Batch - 2016-2021

  • Current designation - Post doctoral Scholar at IIT Gandhinagar

  • Thesis Title - Synthesis of N-Fused Heterocyclic Analogs of Flavonoids and Bioevaluation Studies towards Discovery of Anticancer Agents

Dr. Preeti

  • Batch - 2015-2020

  • Current designation - Principal Scientist in Biocon Biologics Limited

  • Thesis Title - Synthesis and biological evaluation of pyrimidinetrione and its furo-fused derivatives as topoisomerase II inhibitors

Dr. Shailendra Sisodiya

  • Batch - 2014-2019

  • Current designation - Lead Investigator 2, Alembic Pharmaceuticals Limited

  • Thesis Title - Synthesis and bio-evaluation studies of new molecular motifs as potential topoisomerase II inhibitors

Dr. Neha Hura

  • Batch - 2012-2017

  • DST-INSPIRE Fellow

  • Current designation - Strategic Project Manager, Novartis Canada.

  • Thesis Title - Combretastatin A-4 Inspired Heterocyclic Compounds as Antitubulins: Synthesis and Bio-Evaluation Studies


Dr. Garima Priyadarshani

  • Batch - 2011-2016

  • Current designation - Senior Scientist II, SchrÖdinger

  • Thesis Title - Scaffold Hopping of Flavonoids: Synthetic Exploration and Studies of Topoisomerase II– Targeting Anticancer Activities

Dr. Meenu Saini

  • Batch - 2014-2019

  • CSIR-UGC NET Fellow

  • Current designation - Research Manager at Sun Pharmaceutical Industries Limited Gurugram

  • Thesis Title - Synthesis and Biological Studies of Pyridine N-fused Heterocyclic Derivatives as Topoisomerase II Inhibitors


Dr. Suyog Madhav Amrutkar

  • Batch - 2012-2017

  • Current designation - Manager-Scientific Intelligence Group, Amneal Pharmaceutical Ltd. Ahmedabad

  • Thesis Title - Investigation of fused N-heterocyclic compounds as potential hTopo-II inhibitors

Dr. Neha Tripathi

  • Batch - 2012-2017

  • CSIR-NET Fellow, DBT-BINC Qualified

  • Current designation - Research Scientist in Drug discovery team, Aqemia, Paris, Île-de-France, France

  • Thesis Title - Pharmacoinformatics Analysis of Human Topoisomerase IIα: Identifying New Opportunities in Anticancer Drug Design



Dr. Vikas Chaudhary

  • Batch - 2009-2014

  • CSIR-NET Fellow

  • Thesis Title - Novel Heterocyclic-Condensed Purines: Synthetic Exploration and Bio-evaluation Studies



Dr. Maneesh Kashyap

  • Batch - 2008-2013

  • Current designation - Scientist - Project Management (Research & Planning) - NIPER SAS Nagar

  • Thesis Title - Synthesis and Biological Evaluation of Indenoindolones and their Derivatives as Topoisomerase II Inhibitors”

Dr. Ashish Baviskar

  • Batch - 2009-2013

  • Current designation - Senior Research Scientist, Innovation and Development, Abbott Healthcare Pvt. Ltd.

  • Thesis Title - Synthesis, Biological Evaluation and Pre-formulation Studies of N-Fused Imidazole Derivatives as Topoisomerase II Inhibitors

Dr. Chetna (Madaan) Arora

  • Batch - 2007-2011

  • Current designation - Associate Director of Product Management at IQVIA

  • Thesis Title - Development and Application of Multicomponent Reactions in Synthesis of Heterocyclic Compounds as Potential Topoisomerase II Inhibitors.

Former M.S. (Pharm.) Students

Mr. Gautam Sahni

  • Batch - 2020-2022

  • Current designation - Business Analyst at Evalueserve SEZ India

  • Thesis Title - Synthesis of Pyrido-fused diazaphosphinine-4-oxide derivatives as potential anticancer agents



Ms. Mohini Singh

  • Batch - 2020-2022

  • Current designation -QC officer at Biocon Biologics Ltd

  • Thesis Title -Synthesis of Arylidene-imidazo[1,2-a]pyridin-3-one derivatives as potential anticancer agents



Mr. Nabajyoti Patra

  • Batch - 2020-2022

  • Current designation -Pursuing PhD at NIPER S.A.S NAGAR

  • Thesis Title -Synthesis of 2-Arylpyrido[1,2-a]pyrimidin-4-one derivatives as potential anticancer agents



Ms. Nibedita Roy

  • Batch - 2020-2022

  • Current designation - JRF at NIPER S.A.S. NAGAR

  • Thesis Title -Synthesis of Benzodithiazine-1,1-dioxide derivatives as potential DNA polymerase inhibitors



Mr. Prashant Mahadu Chavan

  • Batch - 2020-2022

  • Current designation -Trainee DMPK at Sai Life Sciences Ltd

  • Thesis Title -Synthesis of 3,7-diarylthiazolo [3,2-a] pyrimidin-5-one derivatives as potential anticancer agents



Mr. Rutvij Anil Pokale

  • Batch - 2020-2022

  • Current designation -Senior Scientist at Biocon Biologics Ltd.

  • Thesis Title - Synthesis of arylidenefuro[2,3-d]pyrimidine-2,4,5- triones as potential topoisomerase II inhibitors


Mr. Simranjit Singh Thind

  • Batch - 2020-2022

  • Current designation - Self employed

  • Thesis Title -Synthesis of various amino/ether derivatives of 7-Aryl-thiazolopyrimidin-5-ones as potential anticancer agents


Mr. Susmit Santosh Gogate

  • Batch - 2020-2022

  • Current designation -Junior Associate - Scientific Writing at Indegene

  • Thesis Title -Synthesis of Triazole-benzene-sulfonamide or sulfone derivatives as potential DNA Polymerase Inhibitors


Mr. Vishal Shesharam Tak

  • Batch - 2020-2022

  • Current designation -Tech lead at Baxter Innovations & Business Solutions Pvt Ltd

  • Thesis Title -Synthesis of Arylidine-thiazolo-diazaphosphole-3-oxides as potential anticancer agents


Ms. Kuntala Dey

  • Batch - 2019-2021

  • Current designation - Incoming Grad Student at UF College of Pharmacy, USA (Fall 2022)

  • Thesis Title - Synthesis of Arylmethylidine N-Fused- Azoloimidazolones as Potential Topoisomerase Ⅱ Inhibitors.


Mr. SANJAY C S

  • Batch - 2019-2021

  • Current designation - Analyst at Regional Drug Testing Laboratory, Ernakulam, Kerala

Ms. Ankita Jadhav

  • Batch - 2019-2021

  • Current designation - Scientist at Biocon Biologics Limited, Bangalore.

  • Thesis Title - Synthesis of Triaryl Alkenes: An Approach of Palladium-Catalysed Coupling Reaction of arylalkynes and arylboronic acid .

Mr. Vijay Sanjaysinh Pardeshi

  • Batch - 2019-2021

  • Current designation - Research Associate at Alkem Laboratories Ltd.

Ms. Riya

  • Batch - 2019-2021

  • Current designation - Officer, Analytical research and development, Akums Lifesciences limited Punjab

Ms. Pallavi Saha

  • Batch - 2019-2021

  • Current designation - Ph.D Research Scholar at IIT-BHU (Varanasi).

Mr. Sayan Mondal

  • Batch - 2018-2020

  • Current designation - Patent Research Analyst at Stellarix Consultancy Services Ltd.

  • Thesis Title - Preparation of 2,3-Disubstituted/Functionalized Imidazo[1,2-a]pyridines

Ms. Palak Gupta

  • Batch - 2018-2020

  • Current designation - Graduate student, University of Florida

Ms. Utkarsha Soundankar

  • Batch - 2015-2017

  • Current designation - Senior Research Analyst-Healthcare & Lifesciences, Frost & Sullivan

  • Thesis Title - Investigation of Alternative Carbonylating Agents in the Synthesis of Heterocycles

Mr. Moksha Shah

  • Batch - 2015-2017

  • Current designation - Associate manager-GSC, Eli Lilly and Company

  • Thesis Title - Synthesis of 4-Hetero(Aryl) and 6-Trimethoxyphenyl substituted 3,4- Dihydropyrimidine-2(1H)-Thiones and Pyrimidine-2-Thiols as potential Tubulin Polymerization Inhibitors

Mr. Maharudra Rambhau Dhakne

  • Batch - 2015-2017

  • Thesis Title - Development of method for 3-acylation of indoles

Mr. Pritam Giri

  • Batch - 2015-2017

  • Current designation - PhD student at Konkuk university, Seoul, South Korea

  • Thesis Title - Synthesis of 5-(3,4,5-trimethoxyphenyl)-2-aminoimidazoles with versatile quinoline substitutions as potential tubulin polymerization inhibitors

Mr. Darshan Rameshchandra Sheladiya

  • Batch - 2010-2012

  • Current designation - Jr. Executive, Wockhardt Ltd.

  • Thesis Title - Synthesis of N-Fused Heterocyclic Analogs of Diindolylmethane as Potential Topoisomerase II Inhibitors

Mr. Ajay Chandgude

  • Batch - 2010-2012

  • Current designation -Postdoctoral Research Fellow Harvard University, Dana-Farber Cancer Institute - Harvard Medical School

  • Thesis Title - Development of multicomponent reactions for the synthesis of Imidazoheterocycles: preparation of Zolpidem

Mr. Somnath Gulab Kandekar

  • Batch - 2009-2011

  • Current designation -Scientist, AC Immune SA

  • Thesis Title - Direct C-H bond activation of N-fused imidazoles

Mr. Harshad Kamble

  • Batch - 2008-2010

  • Current designation - Manager (IP), Abbott Healthcare

  • Thesis Title - Design and synthesis of heterocyclic compounds as a potential Topoisomerase II inhibitors

Mr. Balmukund Thakkar

  • Batch - 2007-2009

  • Current designation - Senior Chemist, Cambrex Karlskoga AB, Sweden

  • Thesis Title - Design and synthesis of 4-aminocinnolines as potential antimalarial agents